ECB Bancorp, Inc.
NASDAQ:ECBKBanks - Regional
+$0.50 today
- Market cap
- $181.56M
- Beta
- 0.49
- P/E (TTM)
- 16.4
- EPS (TTM)
- $1.20
Volume 0.01M
Average 0.01M
ECBK EBITDA Margin
EBITDA as a percentage of revenue.
ECB Bancorp, Inc.NASDAQ: ECBK
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to 19.8%
EBITDA Margin was 19.8% in Q1 FY2026, up 9.7 pp from a year earlier. On a trailing-twelve-month basis it was 15.8%, up 6.5 pp year over year. Over 3 fiscal years it widened by 1.0 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 13.4%
- Year-over-year change
- +5.1pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 13.4% | +5.1pp |
| FY2024 | 2024-12-31 | 8.3% | -2.9pp |
| FY2023 | 2023-12-31 | 11.2% | -1.2pp |
| FY2022 | 2022-12-31 | 12.4% | -12.0pp |
| FY2021 | 2021-12-31 | 24.5% | — |
EBITDA Margin vs competitors
How ECBK compares with its peers on the latest reported figures
- ECBK's LTM Mar 2026 EBITDA Margin of 15.8% is the 6th highest of the 9 companies compared; the peer median is 17.8%.
- Its year-over-year change of +6.5 pp is the 3rd highest of 9, against a peer median of +4.7 pp.
- Over three fiscal years its change of +1.0 pp compares with a peer median of -13.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 33.5% | +7.1 pp | -4.4 pp | |
| LTM Mar 2026 | 26.6% | +5.7 pp | +1.9 pp | |
| LTM Mar 2026 | 19.6% | +26.8 pp | -22.9 pp | |
| LTM Mar 2026 | 17.9% | +2.9 pp | -15.4 pp | |
| LTM Mar 2026 | 17.8% | +4.4 pp | -13.7 pp | |
| LTM Mar 2026 | 15.8% | +6.5 pp | +1.0 pp | |
| LTM Mar 2026 | 15.8% | +4.9 pp | -12.8 pp | |
| LTM Mar 2026 | 10.4% | -9.8 pp | -24.5 pp | |
| LTM Mar 2026 | 10.0% | -1.1 pp | — | |
| Peer median (excluding ECBK) | 17.8% | +4.7 pp | -13.7 pp | |
Competitors are the stored peer set for ECBK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 23.6M | 30.56M | 55.83M | 68.27M | 79.51M |
| Cost of Revenue | 4.04M | 8.46M | 30.79M | 42.23M | 47.8M |
| Gross Profit | 19.56M | 22.1M | 25.04M | 26.04M | 31.71M |
| Gross Margin | 82.9% | 72.3% | 44.9% | 38.1% | 39.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 10.83M | 11.33M | 13.85M | 15.2M | 2.01M |
| Operating Expenses | 14.09M | 18.61M | 19.05M | 20.67M | 21.33M |
| Depreciation & Amortization | 300K | 302K | 279K | 302K | 297K |
| EBITDA | 5.77M | 3.8M | 6.26M | 5.67M | 10.68M |
| EBITDA Margin | 24.5% | 12.4% | 11.2% | 8.3% | 13.4% |
| Operating Income | 5.47M | 3.5M | 5.99M | 5.37M | 10.38M |
| Operating Margin | 23.2% | 11.4% | 10.7% | 7.9% | 13.1% |
| Interest Income | 22.38M | 29.16M | 54.78M | 67.05M | 78.18M |
| Interest Expense | 3.68M | 5.52M | 29.99M | 42.06M | 46.26M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 5.47M | 3.5M | 5.99M | 5.37M | 10.38M |
| Pre-Tax Margin | 23.2% | 11.4% | 10.7% | 7.9% | 13.1% |
| Income Tax Expense | 1.43M | 776K | 1.53M | 1.38M | 2.61M |
| Net Income | 4.04M | 2.72M | 4.46M | 3.99M | 7.77M |
| Net Margin | 17.1% | 8.9% | 8.0% | 5.8% | 9.8% |
| EPS (Basic) | 0.33 | 0.32 | 0.53 | 0.48 | 0.96 |
| EPS (Diluted) | 0.33 | 0.32 | 0.52 | 0.48 | 0.94 |
| Weighted Avg Shares | 12.23M | 8.46M | 8.47M | 8.26M | 8.1M |
| Weighted Avg Shares (Diluted) | 12.23M | 8.46M | 8.52M | 8.35M | 8.31M |
ECB Bancorp, Inc.
NASDAQ:ECBK
Intrinsic Alpha fair value
Locked
Current Price
$20.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.